Long-term doppler echocardiographic results of aortic or mitral valve replacement with biocor porcine bioprosthesis Pia S.U. Mykén, MD, PhDa, Håkan E.

Slides:

Advertisements

Similar presentations

Objective assessment of gastroesophageal reflux after short esophagomyotomy for achalasia with the use of manometry and pH monitoring John M. Streitz,

Advertisements

The additional hospital costs generated in the management of complications of pacemaker and defibrillator implantations T.Bruce Ferguson, MD, Candice Lilley.

Tubular heart valves: A new tissue prosthesis design—Preclinical evaluation of the 3F aortic bioprosthesis James L. Cox, MD, Niv Ad, MD, Keith Myers, BS,

W. R. Eric Jamieson, MD, Clifton T. P. Lewis, MD, Marc P

Max B. Mitchell, MD The Journal of Thoracic and Cardiovascular Surgery

Of mice and men and surgical transcatheter aortic valve insertion

Ten-year trends in heart valve replacement operations

Survival Benefit of Aortic Valve Replacement in Patients With Severe Aortic Stenosis With Low Ejection Fraction And Low Gradient With Normal Ejection.

Aortic valve replacement in low-flow, low-gradient aortic stenosis: Left ventricular ejection fraction matters Victor Dayan, MD, PhD, Philippe Pibarot,

Ralph J. Lewis, MD The Journal of Thoracic and Cardiovascular Surgery

Tirone E. David, MD, James Kuo, MD, Susan Armstrong, MSc

Prospective randomized comparison of CarboMedics and St

B. Albat, MD, P. Messner-Pellenc, MD, A. Thévenet, MD

Ten-year trends in heart valve replacement operations

Reoperative “valve-in-valve” transapical transcatheter mitral valve replacement in a high-risk patient with a recent transapical transcatheter aortic.

Long-Term Outcomes of the Mosaic Bioprosthesis

Bicuspid aortic valve aortopathy: One size fits all?

Risk-corrected impact of mechanical versus bioprosthetic valves on long-term mortality after aortic valve replacement Ole Lund, MD, PhD, Martin Bland,

Mitral valve operation in patients with the Marfan syndrome

Zohair Al Halees, MD, Mahmoud M. Awad, MD, Frans Pieters, MD, Maie S

Long-term results of mitral valve repair for myxomatous disease with and without chordal replacement with expanded polytetrafluoroethylene sutures Tirone.

Editorial: The core of leadership

Jian Ye, MDa, Luojia Yang, MDa, Marc R

The variability of the mitral valve anatomy and terminology

Are older patients with mechanical heart valves at increased risk?

Assessment of effective orifice area of prosthetic aortic valves with Doppler echocardiography: An in vivo and in vitro study Odd Bech-Hanssen, MD, PhDa,

Long-term evaluation of biological versus mechanical prosthesis use at reoperative aortic valve replacement Vincent Chan, MD, MPH, B-Khanh Lam, MD, MPH,

Viscoelasticity of dynamically fixed bioprosthetic valves. II

Support Your Specialty

Quality of mitral valve surgery at the United States Department of Veterans Affairs Juan A. Crestanello, MD The Journal of Thoracic and Cardiovascular.

W. R. Eric Jamieson, MD, Clifton T. P. Lewis, MD, Marc P

Transcatheter aortic valve replacement in intermediate-risk patients

Innovation and science: The future of valve design

Michele Gallo, MD, Gino Gerosa, MD

Intermediate results of isolated mitral valve replacement with a Biocor porcine valve Giulio Rizzoli, MD, Tomaso Bottio, MD, PhD, Vladimiro Vida, MD,

Intermediate-Term Outcome Of Mitral Reconstruction In Cardiomyopathy

Transcatheter aortic valve replacement and surgical aortic valve replacement: Both excellent therapies J. James Edelman, MBBS(Hons), PhD, Vinod H. Thourani,

Fifteen years of experience with ATS mechanical heart valve prostheses

Robert W. Emery, MD, Christopher C. Krogh, Kit V. Arom, MD, PhD, Ann M

Surgery for aortic and mitral valve disease in the United States: A trend of change in surgical practice between 1998 and 2005 Scott D. Barnett, PhD,

Kevin Bridge, MD, MSPH, Robert Saeid Farivar, MD, PhD

The Journal of Thoracic and Cardiovascular Surgery

Switch back: Using the pulmonary autograft to replace the aortic valve after arterial switch operation Mark G. Hazekamp, MD, PhDa, Paul H. Schoof, MDa,

Midterm evaluation of the Tissuemed (Aspire) porcine bioprosthesis: 493 patients, 506 bioprostheses Ira R.A Goldsmith, MD, Tomasz J Spyt, Maria Boehm,

Fenton H. McCarthy, MD, MS, Nimesh D. Desai, MD, PhD

Replicating the success of mitral valve repair in the aortic valve

Patient recovery after intermittent disc escape and spontaneous recession of a mechanical heart valve Francis Robicsek, MD, PhD, Joseph W. Cook, MD

Bhawna Gupta, PhD, Ali Dodge-Khatami, MD, PhD, Charles D

Commentary: Bioprosthetic aortic valve replacement: A high standard of comparison for transcatheter aortic valve implantation Aaron Martin, MD, Michael.

Combined valve replacement and myocardial revascularization

Elspeth M. Brown, MRCP, Anthony P. Salmon, FRCP, Robert K. Lamb, FRCS

Biomaterials for heart valve replacement: Conjectures and refutations

The Journal of Thoracic and Cardiovascular Surgery

Warfarin or aspirin after mitral valve repair: Why work harder?

Hans-Joachim Schäfers, MD

Transcatheter aortic valve replacement for prime time unrestricted distribution? Not so fast, my friend G. Michael Deeb, MD, John Carroll, MD The Journal.

Arnt E Fiane, MD, Odd R Geiran, MD, PhD, Jan L Svennevig, MD, PhD

Human factors and cardiac surgery: A multicenter study

Discussion The Journal of Thoracic and Cardiovascular Surgery

Severe tricuspid or mitral regurgitation in inoperable patients with aortic stenosis. Can we leave them alone? Juan A. Crestanello, MD The Journal of.

Permanent pacemaker insertion following transcatheter aortic valve replacement: Not infrequent, not benign, and becoming predictable Craig M. Jarrett,

Commentary: When a choice is not an echo

Long-term clinical experience with the omnicarbon prosthetic valve

Vinay Badhwar, MD, John S. Ikonomidis, MD, PhD, Jeffrey P. Jacobs, MD

Toward a more rational approach in treating type B aortic dissection

Echo-free perfused spaces: A current postoperative finding after homograft replacement of the aortic valve T. Carrel, MD, M. Pasic, MD, E. Oechslin,

Durability of pericardial versus porcine bioprosthetic heart valves

David H. Harpole, MD, Stanley A. Gall, MD, Walter G. Wolfe, MD, J

Descending thoracic and thoracoabdominal aortic aneurysms: “Busted”

Paul Philipp Heinisch, MD, Thierry Carrel, MD

Presentation transcript:

Long-term doppler echocardiographic results of aortic or mitral valve replacement with biocor porcine bioprosthesis Pia S.U. Mykén, MD, PhDa, Håkan E. Berggren, MD, PhDa, Sture Larsson, MD, PhDa, Barbro Roberts, RNa, Ingemar Wallentin, MD, PhDb, Kenneth Caidahl, MD, PhDb The Journal of Thoracic and Cardiovascular Surgery Volume 116, Issue 4, Pages 599-608 (October 1998) DOI: 10.1016/S0022-5223(98)70166-7 Copyright © 1998 Mosby, Inc. Terms and Conditions

Fig. 1 Overview of the total cohort. The patients who are highlighted are presented in this study. AVR, Aortic valve replacement; MVR, mitral valve replacement. *Includes 9 valve-related deaths. †Includes 4 valve-related deaths. The Journal of Thoracic and Cardiovascular Surgery 1998 116, 599-608DOI: (10.1016/S0022-5223(98)70166-7) Copyright © 1998 Mosby, Inc. Terms and Conditions

Fig. 2 Aortic bioprostheses in the group specified as having normal bioprosthetic findings. Mean values for maximum gradients in relation to valve size. The Journal of Thoracic and Cardiovascular Surgery 1998 116, 599-608DOI: (10.1016/S0022-5223(98)70166-7) Copyright © 1998 Mosby, Inc. Terms and Conditions

Fig. 3 Distribution of ejection fractions in each functional class (New York Heart Association) for patients with normal aortic bioprostheses. The Journal of Thoracic and Cardiovascular Surgery 1998 116, 599-608DOI: (10.1016/S0022-5223(98)70166-7) Copyright © 1998 Mosby, Inc. Terms and Conditions

Fig. 4 Normal mitral bioprostheses. Mean values for maximum gradients in relation to valve size. The Journal of Thoracic and Cardiovascular Surgery 1998 116, 599-608DOI: (10.1016/S0022-5223(98)70166-7) Copyright © 1998 Mosby, Inc. Terms and Conditions

Fig. 5 Distribution of ejection fractions in each functional class (New York Heart Association) for patients with a normal mitral bioprosthesis. The Journal of Thoracic and Cardiovascular Surgery 1998 116, 599-608DOI: (10.1016/S0022-5223(98)70166-7) Copyright © 1998 Mosby, Inc. Terms and Conditions